Abstract

Background: Nasopharyngeal carcinoma (NPC) is a malignancy derived from lymphoepithelial tissue andnasopharyngeal epithelial cells. The response therapy of NPC evaluated from histopathological type, but insome patients with the same type was illustrated a different response of therapy. IL-10 expression expects topredict a better response therapy of NPC. IL-10 expression by immunohistochemical examination associatedwith the differentiation of tumors.Method: The study was analytic observational with the cross-sectional approach. Samples were collectedby consecutive sampling and formalin-fixed, paraffin-embedded biopsy specimens were obtained.Result: The result of IL-10 expression in Nasopharyngeal carcinoma (NPC) patients with histopathologicalWorld health organization (WHO) type I was obtained; From all the samples, there were 36.36% of strongpositive expression and 63.64% of frail positive expression. There were increases in the number of cells thatgive a strong expression on WHO type III. Statistical analysis using Fisher’s exact test was obtained p =0.040 with a contingency coefficient of 0.384.Conclusion: There was a moderate correlation between IL-10 expression and histopathological type in NPCpatients.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.